Actuate Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Actuate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Actuate Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actuate Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $60k | 8.9k | 6.69 |
| 2025-06-30 | $14k | 2.3k | 6.11 |
| 2025-03-31 | $13k | 2.0k | 6.77 |
| 2024-12-31 | $15k | 1.9k | 7.96 |